Skip to main content
All lobbying clients

GILEAD SCIENCES INC

Lobbying client · California · filed 2025 to 2026

$21,347,000 Reported spend
92 Filings counted
13 Outside firms hired
8 Bills named

Spend is reported income plus in-house expenses across 92 filings. 2 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 14 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as GILEAD SCIENCES INC., GILEAD SCIENCES, INC.

 Who filed for this client 14

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 8
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    9 filings
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act
    7 filings
  • S. 998
    Medical Supply Chain Resiliency Act
    4 filings
  • H.R. 2213
    Medical Supply Chain Resiliency Act
    3 filings
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    3 filings
  • H.R. 1
    One Big Beautiful Bill Act
    2 filings
  • S. 839
    Safeguarding Honest Speech Act
    2 filings
  • S. 832
    EPIC Act of 2025
    1 filing
 Reported by year 2 years
  • 2026 $9,895,000 39 filings
  • 2025 $11,452,000 53 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 17
  • HOUSE OF REPRESENTATIVES 84
  • SENATE 76
  • Health & Human Services, Dept of (HHS) 23
  • White House Office 17
  • Centers For Medicare and Medicaid Services (CMS) 14
  • Centers For Disease Control & Prevention (CDC) 7
  • Commerce, Dept of (DOC) 7
  • Executive Office of the President (EOP) 7
  • Food & Drug Administration (FDA) 7
  • Natl Institutes of Health (NIH) 7
  • Office of Management & Budget (OMB) 7
  • Patent & Trademark Office (PTO) 7
  • State, Dept of (DOS) 7
  • Treasury, Dept of 7
  • U.S. Trade Representative (USTR) 7
  • Office of Science & Technology Policy (OSTP) 1
  • Office of the Vice President of the United States 1
 Recent filings 94 total
Q3 amendment
GILEAD SCIENCES, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $2,320,000 expenses · posted Oct 21, 2026
View →
Q3 report
GILEAD SCIENCES, INC. Amended
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $6,580,000 expenses · posted Oct 20, 2026
View →
Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View →
Q3 report
FARRAGUT PARTNERS LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View →
Q3 report
MILLER STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · $150,000 income · posted Oct 20, 2026
View →
Q3 report
THE MCMANUS GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
W STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · $60,000 income · posted Oct 19, 2026
View →
Q3 report
THE DUBERSTEIN GROUP INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · $90,000 income · posted Oct 19, 2026
View →
Q3 report
EMPIRE CONSULTING GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
TODD STRATEGY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 19, 2026
View →
Q3 report
TIBER CREEK GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 18, 2026
View →
Q3 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $75,000 income · posted Oct 18, 2026
View →
Q3 report
FORBES-TATE
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 18, 2026
View →
Q3 report
CAPITOL TAX PARTNERS, LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 16, 2026
View →
Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026
View →
Q2 report
TODD STRATEGY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026
View →
Q2 report
FORBES-TATE
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 income · posted Jul 20, 2026
View →
Q2 report
GILEAD SCIENCES, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $1,590,000 expenses · posted Jul 20, 2026
View →
Q2 report
W STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · $60,000 income · posted Jul 20, 2026
View →
Q2 report
JEFFREY J. KIMBELL & ASSOCIATES, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $75,000 income · posted Jul 20, 2026
View →

Showing the 20 most recent of 94 filings. Search the explorer for "GILEAD SCIENCES INC".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem